Retatrutide supplied by NewBioRx must only be handled by trained laboratory personnel familiar with safe chemical handling practices and research material protocols
The SURMOUNT-1 trial (N=2,539), published in the New England Journal of Medicine in 2022 (DOI: 10.1056/NEJMoa2206038), evaluated tirzepatide at 5mg, 10mg, and 15mg weekly doses versus placebo in adults with obesity or overweight
Read Guide In-depth comparison of tirzepatide and semaglutide for weight loss mechanism, side effects, clinical results, and how to think about which is right for you
This high-concentration solution is marketed as a non-surgical way to eliminate stubborn pockets of fat that resist traditional diet and exercise
By mimicking the body's natural hormones, regulating blood sugar, and curbing appetite, it has provided hope for millions of people struggling with type 2 diabetes and chronic obesity